Canada | Science and Enterprise

A company developing a treatment for Covid-19 infections taken as a tablet instead of infusion issued its initial p… https://t.co/iByygVnB9U
about 16 hours ago
New post on Science and Enterprise: Covid-19 Drug Biotech Raises $300M in IPO https://t.co/zwkRakiFk5 #Science #Business
about 16 hours ago
The Food and Drug Administration plans to use organ-on-chip models to test mechanisms for preventing Covid-19 infec… https://t.co/9zAfSK9Nnt
about 21 hours ago
New post on Science and Enterprise: FDA to Use Lung Chip Model for Covid-19 Testing https://t.co/YGwasY1UUJ #Science #Business
about 21 hours ago
Interim results from a clinical trial show a synthetic antibody drug reduces viral burden and medical visits among… https://t.co/bm7JdQ83hT
about 2 days ago

Lilly, NIH Halt Covid-19 Antibody Therapy Trial

By Alan, on October 27th, 2020%

Drug maker Eli Lilly and National Institutes of Health are stopping a clinical trial testing a synthetic antibody to treat hospitalized Covid-19 patients. . . . → Read More: Lilly, NIH Halt Covid-19 Antibody Therapy Trial

New Company IDs Drugs Targeting Cancer Cell Networks

By Alan, on October 7th, 2020%

A start-up company is using artificial intelligence to discover drugs that address the tumor stroma, a cellular network supporting cancerous tumors. . . . → Read More: New Company IDs Drugs Targeting Cancer Cell Networks

Int’l Lab Network to Assess Covid-19 Vaccines

By Alan, on October 2nd, 2020%

Six clinical testing laboratories worldwide plan to evaluate vaccines for protecting against Covid-19 infections with a common set of test protocols. . . . → Read More: Int’l Lab Network to Assess Covid-19 Vaccines

Group Advancing Electronic Spinal Cord Injury Therapies

By Alan, on October 1st, 2020%

A consortium of academic and industry labs is integrating electronic sensors and neural stimulation therapies into an early treatment protocol for spinal cord injuries. . . . → Read More: Group Advancing Electronic Spinal Cord Injury Therapies

Early Trial Results Show Antibody Treating Covid-19

By Alan, on September 16th, 2020%

First results from a clinical trial testing an experimental synthetic antibody, show patients receiving the therapy at a specific dosage, cleared their SARS-CoV-2 viruses within 11 days. . . . → Read More: Early Trial Results Show Antibody Treating Covid-19

Covid-19 Vaccines, Therapies – 31 August 2020

By Alan, on August 31st, 2020%

The European Commission announced today a contribution of €400 million ($US 477 million) to the COVID-19 Vaccine Global Access, or Covax, consortium. . . . → Read More: Covid-19 Vaccines, Therapies – 31 August 2020

Covid-19 Vaccines, Therapies – 17 August 2020

By Alan, on August 17th, 2020%

The number of new Covid-19 therapies increased by eight over the past week to 364, while the number of therapies in clinical trials also jumped by eight. . . . → Read More: Covid-19 Vaccines, Therapies – 17 August 2020

Covid-19 Vaccines, Therapies – 10 August 2020

By Alan, on August 10th, 2020%

Seven new vaccine projects got underway last week, raising the total to 164, with six more vaccines reaching clinical trials now totaling 41. . . . → Read More: Covid-19 Vaccines, Therapies – 10 August 2020

NIH Begins Covid-19 Antibody Trials

By Alan, on August 5th, 2020%

National Institutes of Health is beginning clinical trials of experimental antibody therapies to treat Covid-19 infections in people with symptoms ranging from mild to severe. . . . → Read More: NIH Begins Covid-19 Antibody Trials

Trial Set for Covid-19 Antibodies in Long-Term Care

By Alan, on August 3rd, 2020%

Two companies and NIH are beginning a clinical trial of synthetic antibodies to both treat and prevent Covid-19 infections among people in long-term care. . . . → Read More: Trial Set for Covid-19 Antibodies in Long-Term Care

Science & Enterprise subscription

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise